CompletedNCT06653218

Efficacy and Safety of Stellate Ganglion Block With Lidocaine Combined Platelet-rich Plasma to Treat Chronic Migraine

Studying Rapidly involuting congenital hemangioma

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Beijing Tiantan Hospital
Principal Investigator
Fang Luo, M.D.
Beijing Tiantan Hospital
Intervention
No interventions(other)
Enrollment
200 target
Eligibility
18-75 years · All sexes
Timeline
20242025

Study locations (1)

Collaborators

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology · Qinghai People's Hospital

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06653218 on ClinicalTrials.gov

Other trials for Rapidly involuting congenital hemangioma

Additional recruiting or active studies for the same condition.

See all trials for Rapidly involuting congenital hemangioma

← Back to all trials